Angiotensin Converting Enzyme Inhibitor [EPC]

Angiotensin Converting Enzyme Inhibitor [EPC] was reported 136524 times

Drugs of the Angiotensin Converting Enzyme Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONGENITAL HIATUS HERNIA 157 0.6886
1 GRIP STRENGTH 137 0.5983
2 SWOLLEN JOINT COUNT 118 0.4720
3 LUPUS VULGARIS 562 0.4460
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 835 0.4169
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 220 0.3922
6 HYPOCHOLESTEROLAEMIA 131 0.3711
7 RHEUMATIC FEVER 1628 0.3649
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 238 0.3563
9 C-REACTIVE PROTEIN 329 0.3549
10 SWOLLEN JOINT COUNT INCREASED 1119 0.3506
11 FACET JOINT SYNDROME 1131 0.3470
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 644 0.3105
13 X-RAY ABNORMAL 551 0.3078
14 DISLOCATION OF VERTEBRA 685 0.3000
15 PERIPHERAL VENOUS DISEASE 1170 0.2862
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1934 0.2697
17 DUODENAL ULCER PERFORATION 1990 0.2673
18 RHEUMATOID FACTOR POSITIVE 1471 0.2544
19 RETINITIS 427 0.2470
20 PEMPHIGUS 2764 0.2209
21 MUSCLE INJURY 1634 0.1970
22 C-REACTIVE PROTEIN ABNORMAL 1228 0.1912
23 HELICOBACTER INFECTION 1948 0.1893
24 CATARRH 170 0.1881
25 HAND DEFORMITY 2426 0.1848
26 NEUROLOGIC NEGLECT SYNDROME 101 0.1817
27 STEROID DEPENDENCE 158 0.1800
28 PORPHYRIA ACUTE 252 0.1756
29 FOLLICULITIS 1792 0.1707
30 BREAST CANCER STAGE III 1074 0.1657
31 PRODUCT MONITORING ERROR 232 0.1606
32 OVERLAP SYNDROME 110 0.1571
33 HYPERCHOLESTEROLAEMIA 1476 0.1527
34 CARDIAC SEPTAL DEFECT 109 0.1516
35 ONYCHOMADESIS 595 0.1416
36 LIP DRY 1271 0.1398
37 PERICARDITIS 2348 0.1396
38 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 867 0.1334
39 SYNOVITIS 2329 0.1290
40 GRANULOMA SKIN 104 0.1267
41 BONE EROSION 447 0.1263
42 BLEPHAROSPASM 761 0.1207
43 GLOSSODYNIA 2677 0.1195
44 WOUND INFECTION 1294 0.1180
45 BURSITIS 1416 0.1166
46 SYSTEMIC INFECTION 191 0.1151
47 GRIP STRENGTH DECREASED 992 0.1126
48 DRUG TOLERANCE DECREASED 316 0.1124
49 JOINT RANGE OF MOTION DECREASED 1491 0.1111
50 LIVER INJURY 2684 0.1092
51 RECALLED PRODUCT ADMINISTERED 1031 0.1080
52 LIVE BIRTH 875 0.1045
53 ONYCHOMYCOSIS 456 0.1038
54 JOINT DESTRUCTION 157 0.1009
55 BURNS SECOND DEGREE 175 0.0997
56 WOUND 2732 0.0976
57 SERONEGATIVE ARTHRITIS 111 0.0969
58 BLOOD PRESSURE DIASTOLIC ABNORMAL 244 0.0958
59 AUTOIMMUNE DISORDER 865 0.0887
60 OBESITY 1398 0.0877
61 NAIL DISORDER 758 0.0865
62 CONTRAINDICATED PRODUCT ADMINISTERED 2520 0.0831
63 SYSTEMIC LUPUS ERYTHEMATOSUS 2952 0.0831
64 IRRITABLE BOWEL SYNDROME 1750 0.0815
65 FIBROMYALGIA 1976 0.0812
66 BLOOD PARATHYROID HORMONE DECREASED 118 0.0796
67 PULMONARY FIBROSIS 1456 0.0758
68 FINGER DEFORMITY 366 0.0755
69 PUSTULAR PSORIASIS 253 0.0736
70 TYPE 2 DIABETES MELLITUS 2422 0.0719
71 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 162 0.0703
72 INFUSION SITE REACTION 208 0.0696
73 PSORIATIC ARTHROPATHY 2822 0.0695
74 SCIATICA 1102 0.0691
75 BLOOD PRESSURE SYSTOLIC ABNORMAL 169 0.0683
76 BREATH SOUNDS ABNORMAL 328 0.0665
77 EXOSTOSIS 601 0.0657
78 VENTRICULAR HYPOKINESIA 211 0.0656
79 CARDIAC FAILURE CHRONIC 277 0.0649
80 HYPERKALAEMIA 2244 0.0639
81 ORTHOPNOEA 203 0.0637
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 691 0.0624
83 BRADYARRHYTHMIA 102 0.0620
84 HYPERTENSIVE CRISIS 680 0.0611
85 DYSPNOEA AT REST 177 0.0610
86 TONGUE OEDEMA 231 0.0605
87 HYPOPNOEA 207 0.0596
88 IMPAIRED HEALING 1902 0.0579
89 BENIGN PROSTATIC HYPERPLASIA 298 0.0577
90 PRODUCT LABEL CONFUSION 336 0.0576
91 LEFT VENTRICULAR DYSFUNCTION 380 0.0567
92 DIASTOLIC DYSFUNCTION 175 0.0566
93 PERSONALITY DISORDER 145 0.0553
94 ALCOHOL POISONING 148 0.0552
95 ULCER HAEMORRHAGE 370 0.0546
96 LOWER RESPIRATORY TRACT INFECTION 2475 0.0544
97 ARTHROPATHY 3017 0.0542
98 RHEUMATOID NODULE 149 0.0540
99 RASH VESICULAR 261 0.0539
100 C-REACTIVE PROTEIN INCREASED 1964 0.0539
101 BACK INJURY 587 0.0539
102 WALKING AID USER 352 0.0533
103 CORONARY ARTERY STENOSIS 268 0.0532
104 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 471 0.0532
105 BRONCHIECTASIS 357 0.0529
106 VENTRICULAR DYSFUNCTION 137 0.0528
107 PRESCRIBED OVERDOSE 1014 0.0523
108 ATRIAL TACHYCARDIA 110 0.0523
109 VENTRICULAR ARRHYTHMIA 186 0.0508
110 AORTIC ARTERIOSCLEROSIS 130 0.0505
111 TACHYARRHYTHMIA 126 0.0504
112 BUNDLE BRANCH BLOCK LEFT 214 0.0504
113 PANNICULITIS 121 0.0500
114 MYOSITIS 448 0.0499
115 BLOOD CHOLESTEROL INCREASED 2312 0.0495
116 BREAST CANCER STAGE II 409 0.0491
117 GENERAL PHYSICAL HEALTH DETERIORATION 5640 0.0487
118 EYE INJURY 148 0.0487
119 DILATATION VENTRICULAR 102 0.0485
120 MATERNAL EXPOSURE TIMING UNSPECIFIED 181 0.0481
121 LOWER LIMB FRACTURE 921 0.0479
122 NIGHT SWEATS 1539 0.0477
123 LEFT VENTRICULAR HYPERTROPHY 204 0.0476
124 LUPUS-LIKE SYNDROME 432 0.0476
125 LICHENOID KERATOSIS 108 0.0472
126 AORTIC STENOSIS 163 0.0468
127 ORTHOSTATIC HYPOTENSION 814 0.0467
128 CONGESTIVE CARDIOMYOPATHY 194 0.0465
129 HYPONATRAEMIA 2613 0.0463
130 FOOT DEFORMITY 511 0.0461
131 DRUG TOLERANCE 233 0.0460
132 ATRIOVENTRICULAR BLOCK FIRST DEGREE 199 0.0459
133 PANCREATITIS NECROTISING 104 0.0452
134 BLOOD PRESSURE DIASTOLIC DECREASED 333 0.0451
135 GAIT INABILITY 1506 0.0450
136 DUODENITIS 138 0.0449
137 OSTEOARTHRITIS 1886 0.0444
138 CAROTID ARTERY STENOSIS 154 0.0441
139 EJECTION FRACTION DECREASED 684 0.0440
140 MITRAL VALVE INCOMPETENCE 498 0.0440
141 LEFT VENTRICULAR FAILURE 151 0.0438
142 POTENTIATING DRUG INTERACTION 146 0.0435
143 CONGENITAL ANOMALY 333 0.0430
144 BLOOD PRESSURE SYSTOLIC INCREASED 836 0.0428
145 ELECTROLYTE IMBALANCE 493 0.0424
146 TASTE DISORDER 854 0.0421
147 HIP ARTHROPLASTY 644 0.0420
148 RALES 242 0.0416
149 LABYRINTHITIS 104 0.0411
150 INFUSION RELATED REACTION 2703 0.0407
151 AORTIC VALVE INCOMPETENCE 173 0.0406
152 BLISTER 2270 0.0404
153 ACUTE CORONARY SYNDROME 332 0.0400
154 ANGINA PECTORIS 1140 0.0397
155 TRICUSPID VALVE INCOMPETENCE 316 0.0397
156 GASTRITIS EROSIVE 185 0.0396
157 HYPOVOLAEMIC SHOCK 188 0.0392
158 LACTIC ACIDOSIS 1271 0.0392
159 PRESCRIBED UNDERDOSE 781 0.0391
160 HEPATIC ENZYME INCREASED 2635 0.0386
161 BLOOD CREATINE INCREASED 171 0.0386
162 WHEEZING 2290 0.0386
163 MUSCULOSKELETAL PAIN 2014 0.0384
164 ANGIOEDEMA 1691 0.0382
165 THERAPEUTIC PRODUCT EFFECT DECREASED 1710 0.0381
166 ACUTE KIDNEY INJURY 5836 0.0381
167 GLOMERULAR FILTRATION RATE DECREASED 466 0.0379
168 MELAENA 833 0.0378
169 CIRCULATORY COLLAPSE 637 0.0374
170 STUPOR 120 0.0373
171 OBSTRUCTIVE AIRWAYS DISORDER 415 0.0373
172 ERYSIPELAS 187 0.0372
173 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 634 0.0369
174 COELIAC DISEASE 359 0.0366
175 MOBILITY DECREASED 2624 0.0365
176 NORMAL NEWBORN 198 0.0364
177 BRADYCARDIA 1932 0.0364
178 RENAL FAILURE ACUTE 1544 0.0363
179 ELECTROCARDIOGRAM ABNORMAL 284 0.0362
180 EPILEPSY 1088 0.0356
181 PEMPHIGOID 267 0.0353
182 LUNG DISORDER 1733 0.0353
183 ATRIOVENTRICULAR BLOCK COMPLETE 236 0.0352
184 BODY TEMPERATURE DECREASED 346 0.0351
185 UROSEPSIS 323 0.0350
186 EXERCISE TOLERANCE DECREASED 201 0.0349
187 CARDIAC MURMUR 302 0.0349
188 COMA SCALE ABNORMAL 101 0.0348
189 DELIRIUM 1205 0.0347
190 ARTERIOSCLEROSIS CORONARY ARTERY 230 0.0347
191 HEPATIC CIRRHOSIS 646 0.0343
192 RHEUMATOID ARTHRITIS 3877 0.0341
193 OEDEMA 1851 0.0341
194 HYPOMAGNESAEMIA 473 0.0339
195 SOPOR 449 0.0339
196 HYPOVOLAEMIA 198 0.0338
197 CEREBRAL ISCHAEMIA 174 0.0338
198 INFLAMMATION 1743 0.0337
199 SKIN NECROSIS 175 0.0337
200 POLYARTHRITIS 177 0.0335
201 IRON DEFICIENCY 151 0.0335
202 PATENT DUCTUS ARTERIOSUS 133 0.0335
203 ANGINA UNSTABLE 217 0.0334
204 CEREBRAL HAEMATOMA 112 0.0333
205 ANURIA 286 0.0332
206 BLOOD PRESSURE SYSTOLIC DECREASED 151 0.0332
207 SWOLLEN TONGUE 1034 0.0331
208 DISCOMFORT 2019 0.0331
209 STOMATITIS 2006 0.0330
210 DERMATITIS EXFOLIATIVE 163 0.0325
211 EUGLYCAEMIC DIABETIC KETOACIDOSIS 134 0.0324
212 BLOOD PRESSURE DIASTOLIC INCREASED 149 0.0323
213 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 131 0.0321
214 LIVER FUNCTION TEST INCREASED 687 0.0320
215 SWELLING 2990 0.0319
216 DUODENAL ULCER 225 0.0319
217 COLITIS MICROSCOPIC 151 0.0318
218 CARDIOGENIC SHOCK 457 0.0318
219 ANGIOPATHY 178 0.0317
220 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 325 0.0316
221 PRODUCT PRESCRIBING ERROR 752 0.0315
222 RHINITIS 254 0.0315
223 CONFUSIONAL STATE 5077 0.0314
224 JOINT DISLOCATION 332 0.0314
225 SINUS BRADYCARDIA 298 0.0308
226 RED CELL DISTRIBUTION WIDTH INCREASED 128 0.0308
227 TROPONIN INCREASED 233 0.0306
228 KNEE ARTHROPLASTY 644 0.0306
229 INTERNATIONAL NORMALISED RATIO INCREASED 870 0.0305
230 CARDIAC FAILURE 2445 0.0304
231 PAROSMIA 229 0.0303
232 HEART DISEASE CONGENITAL 107 0.0302
233 PRESYNCOPE 734 0.0302
234 HEMIPLEGIA 251 0.0301
235 ACUTE MYOCARDIAL INFARCTION 888 0.0301
236 EMBOLIC STROKE 106 0.0301
237 RHABDOMYOLYSIS 1255 0.0301
238 DRUG INTERACTION 4772 0.0300
239 ISCHAEMIC STROKE 536 0.0300
240 GINGIVAL PAIN 239 0.0300
241 SLEEP DISORDER 2103 0.0298
242 MUSCULOSKELETAL STIFFNESS 2607 0.0297
243 RECTAL HAEMORRHAGE 1277 0.0297
244 ABNORMAL LOSS OF WEIGHT 202 0.0296
245 JOINT SWELLING 3572 0.0296
246 OLIGURIA 183 0.0294
247 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 149 0.0294
248 DRUG INTOLERANCE 2807 0.0290
249 CAROTID ARTERY OCCLUSION 106 0.0290
250 ACUTE PULMONARY OEDEMA 163 0.0290
251 VENTRICULAR SEPTAL DEFECT 166 0.0290
252 VENTRICULAR TACHYCARDIA 472 0.0286
253 HEMIPARESIS 481 0.0284
254 GANGRENE 170 0.0282
255 HYPOGLYCAEMIA 1361 0.0280
256 HEPATITIS 714 0.0279
257 VENTRICULAR FIBRILLATION 309 0.0278
258 SPONDYLITIS 101 0.0277
259 HYPOKALAEMIA 1282 0.0277
260 BLOOD URIC ACID INCREASED 159 0.0275
261 INTENTIONAL PRODUCT USE ISSUE 2401 0.0274
262 ATRIOVENTRICULAR BLOCK 211 0.0273
263 RESPIRATORY RATE INCREASED 242 0.0272
264 LIP OEDEMA 115 0.0271
265 TUBULOINTERSTITIAL NEPHRITIS 508 0.0271
266 DRUG-INDUCED LIVER INJURY 850 0.0271
267 MATERNAL EXPOSURE DURING PREGNANCY 2410 0.0270
268 POLYURIA 221 0.0270
269 INJURY 1896 0.0269
270 PANCREATITIS ACUTE 605 0.0269
271 LIP SWELLING 896 0.0269
272 HYPERTENSION 5693 0.0268
273 CHOLESTASIS 516 0.0268
274 BUNDLE BRANCH BLOCK RIGHT 123 0.0268
275 HYPERURICAEMIA 110 0.0267
276 HEPATITIS CHOLESTATIC 161 0.0267
277 BLOOD PRESSURE FLUCTUATION 641 0.0267
278 DRY MOUTH 2162 0.0266
279 MYOPATHY 230 0.0266
280 URINE ABNORMALITY 120 0.0264
281 SYNCOPE 2624 0.0262
282 GAMMA-GLUTAMYLTRANSFERASE INCREASED 578 0.0261
283 DYSPNOEA EXERTIONAL 982 0.0260
284 CORONARY ARTERY DISEASE 788 0.0260
285 OEDEMA PERIPHERAL 3166 0.0259
286 NOCTURIA 314 0.0258
287 DRUG LEVEL ABOVE THERAPEUTIC 118 0.0257
288 ATRIAL FIBRILLATION 2497 0.0256
289 POLYP 167 0.0255
290 HAEMATOMA 660 0.0254
291 TENSION HEADACHE 109 0.0253
292 NEPHROTIC SYNDROME 172 0.0251
293 GENERAL SYMPTOM 188 0.0251
294 HYPERTHYROIDISM 362 0.0250
295 INTERNATIONAL NORMALISED RATIO DECREASED 101 0.0249
296 METABOLIC ACIDOSIS 796 0.0249
297 BLOOD PRESSURE INADEQUATELY CONTROLLED 148 0.0246
298 SUBARACHNOID HAEMORRHAGE 250 0.0245
299 HAEMATEMESIS 622 0.0245
300 PARKINSONISM 239 0.0245
301 ROAD TRAFFIC ACCIDENT 1020 0.0244
302 NEUTROPENIC SEPSIS 174 0.0243
303 HYPOTENSION 4868 0.0242
304 TACHYPNOEA 329 0.0242
305 ILL-DEFINED DISORDER 1468 0.0241
306 VENTRICULAR EXTRASYSTOLES 250 0.0241
307 PALLOR 655 0.0240
308 CARDIOMEGALY 296 0.0240
309 EOSINOPHILIA 420 0.0239
310 BLOOD UREA INCREASED 401 0.0239
311 MOTOR DYSFUNCTION 244 0.0239
312 MEDICATION ERROR 1313 0.0236
313 HYPERTRANSAMINASAEMIA 164 0.0236
314 MYOCARDIAL ISCHAEMIA 268 0.0235
315 GOUT 421 0.0234
316 FAECALOMA 128 0.0233
317 BLOOD LACTIC ACID INCREASED 123 0.0233
318 BLOOD POTASSIUM INCREASED 379 0.0233
319 ATRIAL FLUTTER 186 0.0233
320 FLANK PAIN 218 0.0232
321 HEPATITIS ACUTE 151 0.0232
322 SENSORY LOSS 187 0.0232
323 HYPOCALCAEMIA 439 0.0232
324 RENAL CYST 184 0.0231
325 HIATUS HERNIA 299 0.0231
326 IRON DEFICIENCY ANAEMIA 213 0.0231
327 HAEMATURIA 790 0.0230
328 ACIDOSIS 176 0.0230
329 TREATMENT FAILURE 1904 0.0230
330 SHOCK HAEMORRHAGIC 187 0.0229
331 ARTERIAL OCCLUSIVE DISEASE 180 0.0229
332 JAUNDICE 616 0.0229
333 CARDIOMYOPATHY 338 0.0228
334 BLOOD CREATININE INCREASED 1493 0.0228
335 NEUTROPHIL COUNT INCREASED 234 0.0228
336 HEART RATE DECREASED 802 0.0228
337 LIVER FUNCTION TEST ABNORMAL 663 0.0228
338 ABDOMINAL DISCOMFORT 3813 0.0227
339 FREQUENT BOWEL MOVEMENTS 614 0.0227
340 ISCHAEMIA 104 0.0226
341 BLOOD CREATINE PHOSPHOKINASE INCREASED 651 0.0226
342 COORDINATION ABNORMAL 314 0.0225
343 ADVERSE REACTION 297 0.0224
344 LIVER DISORDER 991 0.0223
345 UPPER GASTROINTESTINAL HAEMORRHAGE 375 0.0223
346 DYSLIPIDAEMIA 113 0.0222
347 TRANSIENT ISCHAEMIC ATTACK 746 0.0221
348 SPINAL OSTEOARTHRITIS 194 0.0221
349 MUSCULAR WEAKNESS 2501 0.0220
350 ATRIAL SEPTAL DEFECT 184 0.0219
351 HAEMATOCHEZIA 1210 0.0219
352 THERAPY NON-RESPONDER 982 0.0218
353 HYPERLIPIDAEMIA 261 0.0218
354 ARTERIOSCLEROSIS 205 0.0218
355 EXTRASYSTOLES 152 0.0218
356 MOUTH SWELLING 125 0.0216
357 FLUID INTAKE REDUCED 108 0.0216
358 DIABETES MELLITUS INADEQUATE CONTROL 382 0.0216
359 AGRANULOCYTOSIS 401 0.0216
360 PROTHROMBIN TIME PROLONGED 129 0.0215
361 SUBDURAL HAEMATOMA 308 0.0215
362 PULMONARY CONGESTION 283 0.0214
363 RENAL FAILURE CHRONIC 165 0.0214
364 PERIPHERAL SWELLING 3301 0.0214
365 GASTRIC ULCER HAEMORRHAGE 117 0.0211
366 HYPERGLYCAEMIA 769 0.0211
367 MICTURITION URGENCY 241 0.0211
368 EXPOSURE DURING PREGNANCY 1311 0.0211
369 HYPOTHERMIA 213 0.0210
370 RESPIRATORY DISORDER 629 0.0210
371 CONTUSION 2016 0.0209
372 GASTROINTESTINAL DISORDER 1875 0.0209
373 ELECTROCARDIOGRAM QT PROLONGED 752 0.0209
374 CARDIAC FAILURE ACUTE 139 0.0208
375 ARRHYTHMIA 987 0.0208
376 BASAL CELL CARCINOMA 322 0.0206
377 DYSPEPSIA 2024 0.0206
378 HYPERCALCAEMIA 254 0.0206
379 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 981 0.0204
380 HYPOPHOSPHATAEMIA 150 0.0203
381 POLYNEUROPATHY 243 0.0203
382 EOSINOPHIL COUNT INCREASED 169 0.0203
383 HEPATOCELLULAR INJURY 287 0.0202
384 PETECHIAE 210 0.0201
385 GASTROOESOPHAGEAL REFLUX DISEASE 1616 0.0201
386 HEPATIC STEATOSIS 373 0.0200
387 INTESTINAL ISCHAEMIA 110 0.0200
388 WHITE BLOOD CELL COUNT INCREASED 765 0.0199
389 CACHEXIA 102 0.0198
390 LUNG INFILTRATION 175 0.0198
391 LARYNGEAL OEDEMA 122 0.0198
392 PURPURA 175 0.0198
393 SKIN ULCER 510 0.0197
394 URINE OUTPUT DECREASED 172 0.0197
395 CHEST PAIN 3636 0.0196
396 CONCOMITANT DISEASE AGGRAVATED 121 0.0196
397 SPINAL PAIN 229 0.0195
398 POSTOPERATIVE WOUND INFECTION 132 0.0195
399 EAR PAIN 379 0.0195
400 VASCULITIS 227 0.0195
401 BRADYKINESIA 115 0.0195
402 TRANSAMINASES INCREASED 432 0.0194
403 DYSARTHRIA 724 0.0192
404 ASPHYXIA 157 0.0192
405 PERIPHERAL COLDNESS 264 0.0192
406 JOINT STIFFNESS 504 0.0192
407 RENAL IMPAIRMENT 1609 0.0191
408 CEREBRAL HAEMORRHAGE 684 0.0191
409 STRESS CARDIOMYOPATHY 111 0.0191
410 DERMATITIS BULLOUS 138 0.0190
411 HAEMODYNAMIC INSTABILITY 145 0.0190
412 MYOCARDITIS 218 0.0190
413 JOINT EFFUSION 131 0.0190
414 DEHYDRATION 2532 0.0190
415 BLOOD PRESSURE INCREASED 2897 0.0189
416 OESOPHAGITIS 207 0.0189
417 WEIGHT FLUCTUATION 198 0.0189
418 ULCER 300 0.0188
419 PULMONARY OEDEMA 839 0.0187
420 LOW BIRTH WEIGHT BABY 148 0.0186
421 EAR INFECTION 495 0.0186
422 GASTROENTERITIS 271 0.0186
423 HEPATOMEGALY 182 0.0185
424 POOR VENOUS ACCESS 191 0.0184
425 ARTHRITIS 1449 0.0184
426 ANAEMIA 3493 0.0183
427 DISABILITY 362 0.0183
428 NECK PAIN 1020 0.0182
429 TOXIC EPIDERMAL NECROLYSIS 277 0.0182
430 HYPOAESTHESIA 2725 0.0182
431 URINE ODOUR ABNORMAL 107 0.0182
432 SHOCK 418 0.0182
433 LIPASE INCREASED 139 0.0181
434 PREGNANCY 363 0.0181
435 OSTEOPOROSIS 744 0.0181
436 MIGRAINE 1719 0.0180
437 HALLUCINATION, VISUAL 380 0.0180
438 MULTI-ORGAN FAILURE 311 0.0180
439 DRUG LEVEL INCREASED 297 0.0179
440 DERMATITIS ALLERGIC 225 0.0179
441 ERECTILE DYSFUNCTION 459 0.0179
442 MYASTHENIA GRAVIS 144 0.0178
443 SLEEP APNOEA SYNDROME 339 0.0177
444 BLOOD SODIUM DECREASED 334 0.0177
445 GASTRITIS 466 0.0177
446 COLITIS ISCHAEMIC 118 0.0175
447 DISORIENTATION 691 0.0174
448 INGUINAL HERNIA 106 0.0174
449 URINARY RETENTION 581 0.0174
450 ALOPECIA 3417 0.0174
451 SUDDEN DEATH 184 0.0174
452 ABDOMINAL PAIN UPPER 3571 0.0173
453 MUSCLE SPASTICITY 213 0.0173
454 TACHYCARDIA 1540 0.0173
455 BLOOD CALCIUM DECREASED 194 0.0172
456 AMNESIA 1120 0.0172
457 BACK DISORDER 278 0.0171
458 BLOOD ALBUMIN DECREASED 135 0.0170
459 DIZZINESS POSTURAL 165 0.0170
460 DYSURIA 626 0.0170
461 NASOPHARYNGITIS 3128 0.0170
462 HEART RATE IRREGULAR 383 0.0169
463 FULL BLOOD COUNT ABNORMAL 179 0.0169
464 CONDITION AGGRAVATED 5140 0.0169
465 ADRENAL INSUFFICIENCY 205 0.0169
466 PROTEINURIA 321 0.0169
467 VERTIGO 1026 0.0168
468 SUPRAVENTRICULAR TACHYCARDIA 161 0.0168
469 CORONARY ARTERY OCCLUSION 230 0.0168
470 PARAESTHESIA 2634 0.0167
471 RASH MACULO-PAPULAR 372 0.0167
472 PLEURAL EFFUSION 1013 0.0166
473 MEMORY IMPAIRMENT 2271 0.0165
474 HYPOTONIA 165 0.0165
475 SINUSITIS 1693 0.0165
476 GASTRIC ULCER 313 0.0165
477 FALL 5480 0.0164
478 HAEMODIALYSIS 138 0.0164
479 APHASIA 495 0.0164
480 DYSPNOEA 9215 0.0163
481 PULMONARY HYPERTENSION 339 0.0163
482 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 276 0.0162
483 BRADYPHRENIA 106 0.0162
484 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 842 0.0161
485 MUSCLE TWITCHING 370 0.0160
486 FAECES DISCOLOURED 348 0.0160
487 KETOACIDOSIS 120 0.0160
488 APNOEA 124 0.0159
489 ABDOMINAL PAIN 3702 0.0159
490 DIVERTICULUM 113 0.0159
491 DECREASED APPETITE 3691 0.0159
492 COLITIS ULCERATIVE 708 0.0158
493 BLOOD PRESSURE DECREASED 1049 0.0158
494 HAEMORRHAGIC STROKE 123 0.0157
495 URTICARIA 2634 0.0157
496 ASTHENIA 5885 0.0156
497 COVID-19 PNEUMONIA 184 0.0156
498 PLATELET COUNT INCREASED 203 0.0156
499 NODULE 203 0.0155
500 POISONING DELIBERATE 147 0.0155
501 HAEMATOCRIT DECREASED 307 0.0155
502 SINUS CONGESTION 209 0.0155
503 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1098 0.0154
504 ASPIRATION 169 0.0154
505 CHROMATURIA 348 0.0154
506 CYANOSIS 241 0.0153
507 ALANINE AMINOTRANSFERASE INCREASED 938 0.0153
508 DIABETIC KETOACIDOSIS 366 0.0152
509 THIRST 272 0.0152
510 SINUS TACHYCARDIA 216 0.0152
511 INFECTION 2199 0.0152
512 COLD SWEAT 266 0.0151
513 LOSS OF CONSCIOUSNESS 1932 0.0151
514 WEIGHT INCREASED 3374 0.0151
515 TORSADE DE POINTES 118 0.0150
516 RENAL FAILURE 1996 0.0150
517 FACIAL PAIN 134 0.0150
518 PALPITATIONS 1757 0.0150
519 ASTHMA 1692 0.0150
520 MULTIPLE ORGAN DYSFUNCTION SYNDROME 423 0.0149
521 DIZZINESS 7444 0.0149
522 IMPAIRED WORK ABILITY 319 0.0149
523 PNEUMONIA 4820 0.0149
524 HYPOKINESIA 216 0.0149
525 MUSCLE SPASMS 2729 0.0149
526 HYPERSENSITIVITY 2757 0.0148
527 RENAL TUBULAR NECROSIS 145 0.0148
528 AFFECT LABILITY 142 0.0147
529 OXYGEN SATURATION DECREASED 829 0.0147
530 GASTROINTESTINAL HAEMORRHAGE 1232 0.0147
531 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 379 0.0147
532 END STAGE RENAL DISEASE 268 0.0147
533 PANCYTOPENIA 820 0.0147
534 EMPHYSEMA 148 0.0147
535 VISUAL FIELD DEFECT 106 0.0147
536 SQUAMOUS CELL CARCINOMA 138 0.0146
537 FACE OEDEMA 247 0.0146
538 VOMITING 6885 0.0146
539 TINNITUS 671 0.0146
540 CYSTITIS 463 0.0145
541 IMPAIRED QUALITY OF LIFE 208 0.0145
542 LIGAMENT SPRAIN 143 0.0144
543 BLOOD PRESSURE ABNORMAL 287 0.0144
544 ASCITES 424 0.0144
545 RIGHT VENTRICULAR FAILURE 101 0.0144
546 HAEMOGLOBIN DECREASED 1475 0.0144
547 EPISTAXIS 1074 0.0143
548 RESTLESSNESS 525 0.0143
549 MUSCLE RIGIDITY 171 0.0143
550 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 111 0.0143
551 MYOCLONUS 170 0.0142
552 MOUTH ULCERATION 300 0.0142
553 DRUG ERUPTION 252 0.0142
554 THROMBOCYTOPENIA 1588 0.0142
555 PAIN IN EXTREMITY 4178 0.0142
556 ATELECTASIS 137 0.0142
557 VITAMIN D DEFICIENCY 138 0.0141
558 NIGHTMARE 489 0.0141
559 TOXIC SKIN ERUPTION 142 0.0141
560 BLOOD ALKALINE PHOSPHATASE INCREASED 348 0.0140
561 HYPERBILIRUBINAEMIA 145 0.0140
562 SALIVARY HYPERSECRETION 140 0.0140
563 PHARYNGEAL OEDEMA 215 0.0140
564 SEPTIC SHOCK 607 0.0139
565 ACUTE RESPIRATORY FAILURE 268 0.0139
566 LEUKOCYTOSIS 252 0.0139
567 RESPIRATORY TRACT INFECTION 362 0.0139
568 URINARY INCONTINENCE 411 0.0139
569 LETHARGY 797 0.0138
570 PRODUCTIVE COUGH 659 0.0138
571 RENAL PAIN 146 0.0138
572 CHOLELITHIASIS 449 0.0137
573 PRODUCT USE ISSUE 2563 0.0136
574 CARDIAC ARREST 1125 0.0136
575 ERYTHEMA MULTIFORME 127 0.0136
576 DIARRHOEA HAEMORRHAGIC 127 0.0136
577 PULMONARY EMBOLISM 1291 0.0136
578 PANCREATITIS 717 0.0136
579 ABDOMINAL PAIN LOWER 343 0.0136
580 ARTHRALGIA 5632 0.0135
581 MUSCULOSKELETAL CHEST PAIN 209 0.0135
582 GAIT DISTURBANCE 2584 0.0135
583 ACCIDENTAL OVERDOSE 492 0.0134
584 PARAESTHESIA ORAL 194 0.0134
585 APATHY 196 0.0134
586 SKIN HAEMORRHAGE 199 0.0134
587 CEREBRAL INFARCTION 328 0.0134
588 HEPATIC CYTOLYSIS 171 0.0134
589 LEUKOPENIA 670 0.0134
590 SWELLING FACE 872 0.0134
591 FLUID RETENTION 681 0.0134
592 PYREXIA 4631 0.0134
593 GENERALISED OEDEMA 165 0.0133
594 BLOOD LACTATE DEHYDROGENASE INCREASED 211 0.0133
595 LOW DENSITY LIPOPROTEIN INCREASED 103 0.0133
596 UNRESPONSIVE TO STIMULI 343 0.0133
597 DIABETES MELLITUS 1012 0.0133
598 HAEMOPTYSIS 370 0.0133
599 FEELING HOT 812 0.0132
600 IMMUNODEFICIENCY 197 0.0132
601 CLOSTRIDIUM DIFFICILE COLITIS 140 0.0132
602 LOCALISED INFECTION 319 0.0132
603 DEPRESSED LEVEL OF CONSCIOUSNESS 521 0.0132
604 DEPRESSION 2991 0.0131
605 ABDOMINAL DISTENSION 1371 0.0131
606 COUGH 3678 0.0131
607 DISTURBANCE IN ATTENTION 707 0.0131
608 MYALGIA 2228 0.0131
609 ASPARTATE AMINOTRANSFERASE INCREASED 695 0.0131
610 LYMPHOPENIA 185 0.0131
611 NEURALGIA 318 0.0131
612 MUCOSAL INFLAMMATION 342 0.0130
613 TOOTH FRACTURE 144 0.0130
614 PNEUMONIA ASPIRATION 326 0.0130
615 TENDON RUPTURE 161 0.0130
616 HAEMORRHAGE INTRACRANIAL 194 0.0130
617 BLOOD GLUCOSE FLUCTUATION 142 0.0129
618 MUSCULOSKELETAL DISCOMFORT 223 0.0129
619 MUSCLE STRAIN 112 0.0129
620 HYPOPHAGIA 328 0.0128
621 MALAISE 5623 0.0128
622 FACIAL PARALYSIS 109 0.0128
623 RESTLESS LEGS SYNDROME 232 0.0127
624 RASH PRURITIC 688 0.0127
625 BLOOD IRON DECREASED 150 0.0126
626 PERICARDIAL EFFUSION 292 0.0126
627 GASTROINTESTINAL INFECTION 113 0.0126
628 WEIGHT DECREASED 3513 0.0126
629 HALLUCINATION 948 0.0126
630 COAGULOPATHY 209 0.0125
631 GROIN PAIN 110 0.0125
632 DEPRESSED MOOD 662 0.0125
633 RIB FRACTURE 256 0.0124
634 HYPERAESTHESIA 102 0.0124
635 EMBOLISM 103 0.0124
636 CHEST DISCOMFORT 1269 0.0124
637 SEPSIS 1381 0.0124
638 DEMENTIA 345 0.0123
639 CHOLECYSTITIS 147 0.0123
640 JOINT INJURY 263 0.0123
641 APPENDICITIS 115 0.0123
642 PHARYNGEAL SWELLING 120 0.0123
643 CELLULITIS 615 0.0122
644 FRACTURE 231 0.0122
645 LIMB DISCOMFORT 377 0.0122
646 SEROTONIN SYNDROME 234 0.0122
647 DIPLOPIA 316 0.0122
648 DIARRHOEA 7851 0.0122
649 MYOCARDIAL INFARCTION 2121 0.0121
650 BODY TEMPERATURE INCREASED 247 0.0121
651 FEELING COLD 337 0.0121
652 TOOTH ABSCESS 123 0.0121
653 ACUTE HEPATIC FAILURE 165 0.0121
654 PYELONEPHRITIS 104 0.0120
655 BLOOD CALCIUM INCREASED 105 0.0120
656 BLOOD BILIRUBIN INCREASED 321 0.0119
657 PHOTOSENSITIVITY REACTION 196 0.0119
658 SKIN LACERATION 129 0.0119
659 HYPOXIA 414 0.0117
660 RETINAL DETACHMENT 108 0.0117
661 COGNITIVE DISORDER 543 0.0116
662 ORAL CANDIDIASIS 153 0.0116
663 RESPIRATORY DISTRESS 320 0.0116
664 DEVICE RELATED INFECTION 178 0.0116
665 DRUG PRESCRIBING ERROR 222 0.0115
666 INCONTINENCE 122 0.0115
667 MUSCLE ATROPHY 146 0.0115
668 RESPIRATORY TRACT CONGESTION 183 0.0115
669 CARDIAC FAILURE CONGESTIVE 925 0.0115
670 STATUS EPILEPTICUS 130 0.0115
671 BLOOD URINE PRESENT 218 0.0115
672 INTERSTITIAL LUNG DISEASE 556 0.0115
673 ATAXIA 136 0.0114
674 GINGIVAL BLEEDING 156 0.0114
675 BRONCHOSPASM 163 0.0114
676 TENDERNESS 119 0.0114
677 INTERVERTEBRAL DISC PROTRUSION 249 0.0114
678 DYSPHAGIA 1079 0.0114
679 BACTERIAL INFECTION 212 0.0114
680 FATIGUE 8837 0.0113
681 PNEUMONITIS 309 0.0113
682 STEVENS-JOHNSON SYNDROME 252 0.0113
683 HYPOTHYROIDISM 361 0.0113
684 BLADDER DISORDER 112 0.0113
685 RASH 4909 0.0112
686 RESPIRATORY FAILURE 816 0.0112
687 THROMBOTIC MICROANGIOPATHY 109 0.0112
688 MASS 156 0.0112
689 NEPHROPATHY TOXIC 125 0.0111
690 VISUAL IMPAIRMENT 1379 0.0111
691 TENDONITIS 172 0.0111
692 EATING DISORDER 236 0.0111
693 DEEP VEIN THROMBOSIS 720 0.0111
694 DIVERTICULITIS 306 0.0110
695 LYMPHOCYTE COUNT DECREASED 194 0.0110
696 SKIN LESION 301 0.0110
697 ABSCESS 174 0.0109
698 SENSORY DISTURBANCE 175 0.0109
699 HYPERHIDROSIS 1404 0.0109
700 LABORATORY TEST ABNORMAL 321 0.0109
701 HEAD INJURY 344 0.0109
702 POST PROCEDURAL HAEMORRHAGE 126 0.0108
703 NEPHROPATHY 101 0.0108
704 SINUS DISORDER 214 0.0108
705 COLITIS 408 0.0108
706 PRODUCT USE IN UNAPPROVED INDICATION 2664 0.0107
707 HEART RATE INCREASED 1061 0.0107
708 ANAPHYLACTIC REACTION 591 0.0107
709 SPEECH DISORDER 560 0.0107
710 PAIN 6541 0.0106
711 COMA 507 0.0106
712 HEPATOTOXICITY 237 0.0106
713 ECZEMA 557 0.0106
714 INSOMNIA 2834 0.0106
715 CEREBROVASCULAR ACCIDENT 1795 0.0106
716 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 101 0.0106
717 URINARY TRACT INFECTION 1796 0.0105
718 ENCEPHALOPATHY 257 0.0105
719 CHRONIC KIDNEY DISEASE 795 0.0105
720 ILEUS 130 0.0105
721 BALANCE DISORDER 904 0.0104
722 PRODUCT ADMINISTRATION ERROR 211 0.0104
723 CANDIDA INFECTION 176 0.0104
724 UPPER RESPIRATORY TRACT INFECTION 480 0.0104
725 NAUSEA 8215 0.0104
726 OROPHARYNGEAL PAIN 959 0.0103
727 GLYCOSYLATED HAEMOGLOBIN INCREASED 261 0.0103
728 PARALYSIS 148 0.0103
729 DRUG LEVEL DECREASED 105 0.0103
730 AGITATION 757 0.0103
731 SOMNOLENCE 2060 0.0102
732 HEPATIC FAILURE 308 0.0102
733 CARDIOVASCULAR DISORDER 258 0.0102
734 BLOOD TRIGLYCERIDES INCREASED 179 0.0101
735 HEAD DISCOMFORT 179 0.0101
736 RETCHING 215 0.0101
737 GASTROENTERITIS VIRAL 182 0.0101
738 HAEMORRHOIDS 195 0.0100
739 FLATULENCE 565 0.0100
740 RED BLOOD CELL COUNT DECREASED 284 0.0099
741 HEADACHE 6212 0.0099
742 SPLENOMEGALY 116 0.0099
743 PRURITUS 3785 0.0098
744 CATARACT 586 0.0098
745 GENERALISED TONIC-CLONIC SEIZURE 162 0.0098
746 PARANOIA 168 0.0097
747 EYE HAEMORRHAGE 130 0.0097
748 POLLAKIURIA 403 0.0097
749 BRONCHITIS 714 0.0096
750 ADVERSE DRUG REACTION 864 0.0096
751 INTENTIONAL OVERDOSE 616 0.0096
752 SUICIDE ATTEMPT 580 0.0096
753 EYELID OEDEMA 111 0.0095
754 DEAFNESS 247 0.0094
755 BLOOD TEST ABNORMAL 132 0.0094
756 SNEEZING 210 0.0094
757 SMALL INTESTINAL OBSTRUCTION 115 0.0093
758 PRURITUS GENERALISED 202 0.0093
759 FEBRILE NEUTROPENIA 619 0.0093
760 MENTAL IMPAIRMENT 226 0.0093
761 PREMATURE BABY 280 0.0093
762 OSTEONECROSIS OF JAW 230 0.0093
763 TOOTH INFECTION 122 0.0092
764 THERAPEUTIC RESPONSE DECREASED 561 0.0092
765 ADVERSE EVENT 846 0.0092
766 BACK PAIN 2121 0.0091
767 INTENTIONAL SELF-INJURY 184 0.0091
768 INTESTINAL PERFORATION 102 0.0091
769 MOVEMENT DISORDER 291 0.0091
770 THROAT TIGHTNESS 245 0.0090
771 CONSTIPATION 1955 0.0090
772 RASH ERYTHEMATOUS 428 0.0089
773 GASTRIC HAEMORRHAGE 103 0.0089
774 CARDIO-RESPIRATORY ARREST 372 0.0089
775 PNEUMOTHORAX 141 0.0089
776 LUNG INFECTION 138 0.0089
777 SKIN REACTION 125 0.0089
778 PSORIASIS 1158 0.0089
779 ANAPHYLACTIC SHOCK 228 0.0088
780 GLAUCOMA 170 0.0088
781 BLOOD GLUCOSE ABNORMAL 163 0.0088
782 BRAIN FOG 138 0.0088
783 PSYCHOTIC DISORDER 260 0.0088
784 PSYCHOMOTOR HYPERACTIVITY 146 0.0088
785 ANOREXIA 113 0.0088
786 MUSCLE TIGHTNESS 142 0.0088
787 THYROID DISORDER 135 0.0087
788 SPINAL FRACTURE 175 0.0087
789 PULMONARY MASS 130 0.0087
790 POOR QUALITY SLEEP 187 0.0087
791 SKIN DISORDER 289 0.0087
792 HERNIA 166 0.0086
793 ORAL PAIN 192 0.0086
794 FOETAL EXPOSURE DURING PREGNANCY 697 0.0086
795 ANXIETY 2440 0.0086
796 TREMOR 1420 0.0085
797 DIALYSIS 121 0.0085
798 ANOSMIA 123 0.0085
799 UNDERDOSE 619 0.0085
800 LACRIMATION INCREASED 256 0.0085
801 ALTERED STATE OF CONSCIOUSNESS 183 0.0084
802 OFF LABEL USE 7395 0.0084
803 HALLUCINATION, AUDITORY 134 0.0084
804 LYMPHADENOPATHY 298 0.0084
805 BLOOD POTASSIUM DECREASED 253 0.0084
806 RHINORRHOEA 543 0.0084
807 ERYTHEMA 1720 0.0084
808 GALLBLADDER DISORDER 148 0.0083
809 INFLUENZA 920 0.0082
810 SCAR 141 0.0082
811 VIRAL INFECTION 274 0.0082
812 CLOSTRIDIUM DIFFICILE INFECTION 178 0.0081
813 BRAIN OEDEMA 103 0.0081
814 SECRETION DISCHARGE 102 0.0081
815 AGGRESSION 406 0.0081
816 UVEITIS 110 0.0081
817 DYSGEUSIA 600 0.0081
818 POST PROCEDURAL COMPLICATION 155 0.0081
819 RENAL DISORDER 372 0.0080
820 BEDRIDDEN 104 0.0079
821 CHOKING 154 0.0079
822 VISION BLURRED 1083 0.0079
823 TOXICITY TO VARIOUS AGENTS 1327 0.0079
824 BONE DISORDER 143 0.0078
825 DYSSTASIA 229 0.0078
826 QUALITY OF LIFE DECREASED 105 0.0078
827 MYELODYSPLASTIC SYNDROME 113 0.0078
828 SKIN DISCOLOURATION 359 0.0078
829 HAEMORRHAGE 816 0.0078
830 METASTASES TO LIVER 137 0.0078
831 OSTEOPENIA 118 0.0078
832 STAPHYLOCOCCAL INFECTION 255 0.0077
833 DERMATITIS 161 0.0077
834 INJECTION SITE REACTION 528 0.0077
835 CARPAL TUNNEL SYNDROME 107 0.0076
836 NEUTROPENIA 1036 0.0076
837 CHILLS 893 0.0076
838 INCORRECT PRODUCT ADMINISTRATION DURATION 165 0.0076
839 FEMUR FRACTURE 232 0.0075
840 FLUID OVERLOAD 109 0.0075
841 NEPHROLITHIASIS 341 0.0074
842 METASTASES TO BONE 122 0.0074
843 FLUSHING 751 0.0074
844 PREMATURE DELIVERY 117 0.0073
845 VISUAL ACUITY REDUCED 244 0.0073
846 RASH MACULAR 256 0.0073
847 ACUTE RESPIRATORY DISTRESS SYNDROME 129 0.0073
848 HERPES ZOSTER 419 0.0073
849 THROMBOSIS 585 0.0073
850 ACUTE MYELOID LEUKAEMIA 113 0.0072
851 DYSPHONIA 423 0.0072
852 CARDIAC DISORDER 672 0.0072
853 SKIN EXFOLIATION 605 0.0072
854 CONJUNCTIVITIS 133 0.0072
855 TOOTH DISORDER 159 0.0071
856 AGEUSIA 178 0.0071
857 PAIN IN JAW 202 0.0071
858 DYSKINESIA 289 0.0071
859 LIMB INJURY 192 0.0071
860 FOOT FRACTURE 134 0.0071
861 THROAT IRRITATION 317 0.0071
862 BLOOD GLUCOSE INCREASED 1329 0.0070
863 BONE PAIN 412 0.0070
864 PRODUCT QUALITY ISSUE 955 0.0070
865 INFLUENZA LIKE ILLNESS 578 0.0070
866 INTESTINAL OBSTRUCTION 264 0.0070
867 TREATMENT NONCOMPLIANCE 383 0.0070
868 BONE MARROW FAILURE 142 0.0070
869 SEDATION 183 0.0070
870 RASH GENERALISED 180 0.0069
871 MENTAL DISORDER 296 0.0068
872 ECONOMIC PROBLEM 103 0.0068
873 SKIN CANCER 146 0.0068
874 ABASIA 167 0.0068
875 EYE SWELLING 251 0.0067
876 TOOTHACHE 122 0.0067
877 ANKLE FRACTURE 104 0.0067
878 LOCAL SWELLING 117 0.0067
879 NO ADVERSE EVENT 1214 0.0067
880 BLINDNESS 273 0.0067
881 PANIC ATTACK 244 0.0067
882 PAIN OF SKIN 179 0.0066
883 RASH PAPULAR 149 0.0066
884 PHOTOPHOBIA 125 0.0066
885 SEIZURE 767 0.0066
886 NERVOUSNESS 346 0.0066
887 FEAR 178 0.0066
888 INTENTIONAL PRODUCT MISUSE 577 0.0066
889 OSTEOMYELITIS 119 0.0066
890 ABNORMAL BEHAVIOUR 259 0.0065
891 SUICIDAL IDEATION 598 0.0065
892 BLOOD GLUCOSE DECREASED 310 0.0064
893 ERUCTATION 124 0.0064
894 RENAL INJURY 188 0.0063
895 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1136 0.0063
896 HOT FLUSH 474 0.0063
897 COVID-19 1101 0.0063
898 NEEDLE ISSUE 182 0.0062
899 ORAL HERPES 122 0.0062
900 OVERDOSE 1340 0.0062
901 RESPIRATORY ARREST 171 0.0062
902 KIDNEY INFECTION 121 0.0062
903 PERITONITIS 127 0.0061
904 HIP FRACTURE 194 0.0060
905 DRUG ABUSE 499 0.0060
906 NEUROPATHY PERIPHERAL 569 0.0060
907 EYE PRURITUS 201 0.0060
908 UPPER LIMB FRACTURE 119 0.0060
909 BURNING SENSATION 417 0.0059
910 NEUTROPHIL COUNT DECREASED 240 0.0059
911 HYPOACUSIS 251 0.0058
912 EYE PAIN 327 0.0058
913 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 134 0.0057
914 MALIGNANT NEOPLASM PROGRESSION 587 0.0057
915 GASTRIC DISORDER 195 0.0057
916 MUSCULOSKELETAL DISORDER 108 0.0057
917 NASAL CONGESTION 333 0.0057
918 MIDDLE INSOMNIA 105 0.0056
919 CONVULSION 321 0.0056
920 DRUG INEFFECTIVE 7391 0.0056
921 FEEDING DISORDER 113 0.0056
922 EXTRAPYRAMIDAL DISORDER 138 0.0056
923 MOOD ALTERED 151 0.0055
924 PLATELET COUNT DECREASED 588 0.0055
925 INJECTION SITE MASS 202 0.0055
926 DISEASE RECURRENCE 255 0.0054
927 NEOPLASM PROGRESSION 185 0.0053
928 ACTIVITIES OF DAILY LIVING IMPAIRED 105 0.0053
929 FEELING ABNORMAL 1270 0.0053
930 MENTAL STATUS CHANGES 144 0.0052
931 NERVOUS SYSTEM DISORDER 160 0.0051
932 GYNAECOMASTIA 157 0.0051
933 HYPERSOMNIA 143 0.0050
934 PRODUCT SUBSTITUTION ISSUE 279 0.0048
935 DISEASE PROGRESSION 570 0.0048
936 ABNORMAL DREAMS 133 0.0048
937 HEPATIC FUNCTION ABNORMAL 175 0.0047
938 LUNG NEOPLASM MALIGNANT 188 0.0046
939 DRUG ADMINISTRATION ERROR 136 0.0044
940 WHITE BLOOD CELL COUNT DECREASED 480 0.0044
941 DRY EYE 220 0.0044
942 PROCEDURAL PAIN 122 0.0044
943 OCULAR HYPERAEMIA 208 0.0044
944 CRYING 156 0.0043
945 FUNGAL INFECTION 143 0.0043
946 THERAPEUTIC RESPONSE SHORTENED 141 0.0042
947 IRRITABILITY 250 0.0042
948 ANGER 135 0.0040
949 ILLNESS 398 0.0039
950 EYE DISORDER 126 0.0038
951 PROSTATE CANCER 298 0.0037
952 MOOD SWINGS 118 0.0037
953 DRY SKIN 491 0.0037
954 WITHDRAWAL SYNDROME 149 0.0035
955 HOSPITALISATION 537 0.0035
956 UNEVALUABLE EVENT 249 0.0033
957 DEVICE DISLOCATION 140 0.0032
958 OSTEONECROSIS 105 0.0032
959 NEOPLASM MALIGNANT 204 0.0031
960 DEATH 2612 0.0030
961 PLASMA CELL MYELOMA 115 0.0029
962 WRONG TECHNIQUE IN DRUG USAGE PROCESS 107 0.0029
963 SKIN IRRITATION 132 0.0029
964 DRUG EFFECT INCOMPLETE 103 0.0028
965 EMOTIONAL DISTRESS 328 0.0027
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 190 0.0027
967 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 142 0.0026
968 DRUG EFFECT DECREASED 137 0.0025
969 SURGERY 146 0.0025
970 INJECTION SITE BRUISING 197 0.0025
971 EYE IRRITATION 139 0.0024
972 INCORRECT DOSE ADMINISTERED 539 0.0024
973 INJECTION SITE SWELLING 179 0.0023
974 COMPLETED SUICIDE 193 0.0023
975 PRODUCT DOSE OMISSION 150 0.0023
976 MULTIPLE SCLEROSIS 108 0.0023
977 SKIN BURNING SENSATION 161 0.0022
978 PRODUCT DOSE OMISSION ISSUE 660 0.0022
979 THERAPY CESSATION 115 0.0022
980 INJECTION SITE HAEMORRHAGE 176 0.0022
981 BREAST CANCER 197 0.0021
982 DEVICE MALFUNCTION 148 0.0021
983 INJECTION SITE PAIN 637 0.0021
984 INJECTION SITE PRURITUS 136 0.0020
985 MULTIPLE SCLEROSIS RELAPSE 137 0.0020
986 INJECTION SITE ERYTHEMA 213 0.0017
987 DRUG DOSE OMISSION 247 0.0015
988 ACNE 113 0.0015
989 DRUG WITHDRAWAL SYNDROME 121 0.0014
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 259 0.0013
991 DEVICE ISSUE 103 0.0011
992 DRUG DEPENDENCE 184 0.0011